The Justice Department (DOJ) has been ramping up antitrust enforcement under the Biden administration, despite not having a politically confirmed official to serve as antitrust chief.
The Department shares antitrust authority with the Federal Trade Commission, whose new liberal leadership has drawn much of the early spotlight. Yet in recent months, the DOJ has blocked a major insurance-industry merger between Aon and rival Willis Towers Watson; filed an aggressive challenge to a partnership between American Airlines and JetBlue; and withdrawn from a real-estate industry settlement in order to take a deeper look at whether industry practices keep some broker commissions artificially high.
Antitrust staffers are advancing investigations of business practices at Apple, Google (which already is facing one Justice Department antitrust lawsuit), and Visa. The Department’s antitrust division also is deep into scrutinizing some high-profile pending mergers. Those include a publishing industry deal in which Penguin Random House’s parent company is seeking to buy Simon & Schuster, and UnitedHealth’s planned acquisition of health-care technology company Change Healthcare.
Attorney General Merrick Garland, speaking at the New Yorker Festival on Monday, described the antitrust division as “energized and eager to go forward,” saying the Department had ongoing matters “involving everything from agriculture, to banking, to real estate.”
“We do think that ensuring fair competition is an essential element of our obligation to ensure that justice is done,” he said.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Johns Hopkins and Caltech Settle for $35.3M in College Price-Fixing Lawsuit
Jan 22, 2025 by
CPI
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan